OCULAR DRUG DELIVERY - PHARMACOKINETIC CONSIDERATIONS

被引:134
|
作者
SCHOENWALD, RD
机构
[1] University of Iowa. College of Pharmacy, Iowa City, Iowa
关键词
D O I
10.2165/00003088-199018040-00001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:255 / 269
页数:15
相关论文
共 50 条
  • [21] Ocular drug delivery
    Goepferich, A.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 95 : 157 - 157
  • [22] In vitro cytotoxicity screening and pharmacokinetic modeling: a tool in the development of ocular drug delivery systems
    Tuominen, Eva
    Mihov, George
    Zong, Mengmeng
    Sarkhel, Sanjay
    Dias, Aylvin
    Urtti, Arto
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [23] PHARMACOKINETIC CONSIDERATIONS IN PEPTIDE DRUG DESIGN
    NESTOR, JJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 202 : 193 - MEDI
  • [24] Pharmacokinetic Considerations for Antibody Drug Conjugates
    Kedan Lin
    Jay Tibbitts
    Pharmaceutical Research, 2012, 29 : 2354 - 2366
  • [25] Pharmacokinetic Considerations for Antibody Drug Conjugates
    Lin, Kedan
    Tibbitts, Jay
    PHARMACEUTICAL RESEARCH, 2012, 29 (09) : 2354 - 2366
  • [26] PHARMACOKINETIC CONSIDERATIONS IN RATIONAL DRUG DESIGN
    GUMBLETON, M
    SNEADER, W
    CLINICAL PHARMACOKINETICS, 1994, 26 (03) : 161 - 168
  • [27] Nanoparticles in the ocular drug delivery
    Hong-Yan Zhou
    Ji-Long Hao
    Shuang Wang
    Yu Zheng
    Wen-Song Zhang
    International Journal of Ophthalmology, 2013, 6 (03) : 390 - 396
  • [28] Dendrimers for ocular drug delivery
    Lancina, Michael G., III
    Yang, Hu
    CANADIAN JOURNAL OF CHEMISTRY, 2017, 95 (09) : 897 - 902
  • [29] Redefining ocular drug delivery
    Song, Allisa J.
    Steger, Jennifer S.
    Robin, Alan L.
    OCULAR SURFACE, 2022, 26 : 197 - 199
  • [30] Polysaccharides in Ocular Drug Delivery
    Dubashynskaya, Natallia
    Poshina, Daria
    Raik, Sergei
    Urtti, Arto
    Skorik, Yury A.
    PHARMACEUTICS, 2020, 12 (01)